Read news on IND approval with our app.
Read more in the app
Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor - EurekAlert!
Insilico Medicine received IND approval and o - EurekAlert
Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412 - EurekAlert